Business Description
BioLife Solutions Inc
NAICS : 339113
SIC : 3841
Description
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -0.55 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 4.99 | |||||
| Beneish M-Score | -3.45 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 39.4 | |||||
| 3-Year EPS without NRI Growth Rate | -231.9 | |||||
| Future 3-5Y Total Revenue Growth Rate | 22.71 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.55 | |||||
| 9-Day RSI | 52.55 | |||||
| 14-Day RSI | 50.15 | |||||
| 6-1 Month Momentum % | 2.24 | |||||
| 12-1 Month Momentum % | 2.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.11 | |||||
| Quick Ratio | 3.11 | |||||
| Cash Ratio | 1.44 | |||||
| Days Inventory | 105.05 | |||||
| Days Sales Outstanding | 59.31 | |||||
| Days Payable | 44.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -27.1 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.27 | |||||
| Operating Margin % | -24.08 | |||||
| Net Margin % | -85.79 | |||||
| ROE % | -45.28 | |||||
| ROA % | -27.68 | |||||
| ROIC % | -8.76 | |||||
| ROC (Joel Greenblatt) % | -234.13 | |||||
| ROCE % | -31.33 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.78 | |||||
| EV-to-EBIT | -5.98 | |||||
| EV-to-EBITDA | -6.66 | |||||
| EV-to-Revenue | 5.37 | |||||
| EV-to-Forward-Revenue | 4.58 | |||||
| EV-to-FCF | -60.37 | |||||
| Price-to-Median-PS-Value | 0.89 | |||||
| Price-to-Net-Current-Asset-Value | 17.67 | |||||
| Earnings Yield (Greenblatt) % | -16.72 |
How BioLife Solutions Inc (BLFS) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BLFS
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
BioLife Solutions Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 161.759 | ||
| EPS (TTM) ($) | -3.26 | ||
| Beta | 2.04 | ||
| Volatility % | 75.64 | ||
| 14-Day RSI | 50.15 | ||
| 14-Day ATR ($) | 1.44637 | ||
| 20-Day SMA ($) | 21.399 | ||
| 12-1 Month Momentum % | 2.33 | ||
| 52-Week Range ($) | 10.4 - 26.9576 | ||
| Shares Outstanding (Mil) | 42.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioLife Solutions Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioLife Solutions Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioLife Solutions Inc Frequently Asked Questions
What is BioLife Solutions Inc(BLFS)'s stock price today?
The current price of BLFS is $21.73. The 52 week high of BLFS is $26.96 and 52 week low is $10.40.
When is next earnings date of BioLife Solutions Inc(BLFS)?
The next earnings date of BioLife Solutions Inc(BLFS) is 2023-05-09 Est..
Does BioLife Solutions Inc(BLFS) pay dividends? If so, how much?
BioLife Solutions Inc(BLFS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
